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Abstract
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Brains are constantly flooded with sensory information that needs to be filtered at the preattentional level and integrated into endogenous activity in order to allow for detection of salient
information and an appropriate behavioral response. People with Autism Spectrum Disorder
(ASD) or Fragile X Syndrome (FXS) are often over- or under-reactive to stimulation, leading to a
wide range of behavioral symptoms. This altered sensitivity may be caused by disrupted sensory
processing, signal integration and/or gating, and is often being neglected. Here, we review
translational experimental approaches that are used to investigate sensory processing in humans
with ASD and FXS, and in relevant rodent models. This includes electroencephalographic
measurement of event related potentials, neural oscillations and mismatch negativity, as well as
habituation and pre-pulse inhibition of startle. We outline robust evidence of disrupted sensory
processing in individuals with ASD and FXS, and in respective animal models, focusing on the
auditory sensory domain. Animal models provide an excellent opportunity to examine common
mechanisms of sensory pathophysiology in order to develop therapeutics.
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1. Introduction
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We are continuously bombarded with sensory stimuli in daily life. The appropriate preattentive filtering of this sensory information and its integration into other cognitive
processes are critical for healthy brain function. This is exemplified in autism spectrum
disorder (ASD), in which abnormal filtering and the accompanying hyper-sensitivity or
hypo-sensitivity to sensory stimuli are cardinal symptoms which have a debilitating impact
on social interactions and daily functioning (Crane et al., 2009; Elison et al., 2013;
Elsabbagh et al., 2013; Hirstein et al., 2001; Leekam et al., 2007; Minshew et al., 2002;
Zwaigenbaum et al., 2005). ASD impacts approximately 1 in 68 children in the US, with
nearly five times higher incidence in boys than girls (data from 8 year old children, Autism
and Developmental Disabilities Monitoring (ADDM) Network – CDC, 2010). Individuals
with ASD display a range of symptoms potentially related to sensory disruptions, including
difficulties with social communication/interactions, fixated interests, inflexible routines and
motor stereotypies.

Author Manuscript

Fragile X Syndrome (FXS) is the most common monogenic form of ASD that affects 1 in
4000 males and 1 in 8000 females. FXS occurs due to a mutation in the Fmr1 gene that
results in the down-regulation of fragile × mental retardation protein (FMRP). FMRP is a
translation regulator and its absence causes abnormal protein synthesis particularly those
associated with activity dependent synaptic plasticity. The symptoms of FXS include
intellectual disability, repetitive behaviors, social communication deficits, increased anxiety
and arousal, and abnormal sensory processing. Between one quarter and one third of
individuals with FXS are also diagnosed with ASD (Bailey et al., 2008; Rogers et al., 2001).
Several studies suggest the existence of similar pathophysiological and anatomical
mechanisms in ASD and FXS, particularly in the sensory processing domain (Belmonte and
Bourgeron, 2006; Feinstein and Reiss, 1998; Hagerman, 2006; Pickett and London, 2005;
Reiss et al., 1995).

Author Manuscript

Of all the symptom domains characterizing ASD and FXS, the sensory domain arguably
holds the most promise for revealing mechanisms central to the pathogenesis of the
spectrum of disorders. Sensory processing difficulties in ASD are manifested in
hypersensitivity, avoidance of sensory stimuli, diminished responses to sensory stimulation,
and/or sensory seeking behavior. These symptoms can impact multiple sensory systems
including the visual, auditory, gustatory, olfactory and tactile systems (Ben-Sasson et al.,
2008; Cascio et al., 2015; Foss-Feig et al., 2012; Klintwall et al., 2011; Lane et al., 2014;
Liss et al., 2006; Marco et al., 2012; O’Connor, 2012). Similar sensory system deficits are
also seen in humans with FXS (Baranek et al., 2008; Castrén et al., 2003; Frankland et al.,
2004; Kogan et al., 2004; Miller et al., 1999; Rotschafer and Razak, 2014; Schneider et al.,
2013; Van der Molen et al., 2012a,b). The symptoms can be evaluated by clinical assessment
or parent report (Baranek et al., 2008; Ben-Sasson et al., 2007; Tavassoli et al., 2016) and
have recently been included as a criterion for ASD diagnosis in the Diagnostic and
Statistical Manual of Mental Disorders, 5th edition (DSM-5). Sensory abnormalities in ASD
and FXS are not only among the most replicable features of these disorders (Ben-Sasson et
al., 2008; Donkers et al., 2015; Klintwall et al., 2011; Liss et al., 2006), they are also present
early in childhood (Baranek et al., 2008; Elison et al., 2013; Elsabbagh et al., 2013; Germani
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et al., 2014; Zwaigenbaum et al., 2005) and are strong predictors of some later-emerging
symptoms, such as anxiety (Green et al., 2012; Sullivan et al., 2014). Importantly, sensory
deficits may be accompanied by neurophysiological abnormalities of sensory processing
which can be quantified objectively and non-invasively using electroencephalography (EEG)
(Brandwein et al., 2015; Castrén et al., 2003; Ethridge et al., 2016; Lepisto et al., 2005;
Machado et al., 2013; Orekhova et al., 2007, 2008; Stroganova et al., 2007; Van der Molen
et al., 2012a,b; van Diessen et al., 2014; Wang et al., 2013) or electromyography (EMG)
and/or behavioral measures of pre-pulse inhibition and habituation of the startle reflex (Perry
et al., 2007).

Author Manuscript

In the fields of ASD and FXS research, it is critical to develop translation-relevant outcome
measures which bridge human and animal studies. Experimental approaches which measure
sensory processing are emerging as powerful translational tools in this regard. Studies using
EEG, magnetoencephalography (MEG) or startle/EMG point to analogous sensory
processing deficits in humans and animal models (Castrén et al., 2003; Connolly et al., 2004;
Ehrlichman et al., 2008; Ethridge et al., 2016; Harms et al., 2014; Lovelace et al., 2016;
Maxwell et al., 2004; Nakamura et al., 2011; Siegel et al., 2003; Umbricht et al., 2004) and
have facilitated examination of underlying mechanisms of sensory disorders in rodent
models relevant to ASD/FXS. Furthermore, such studies take advantage of the properties of
the neural circuitry underlying basic sensory processing, which is better characterized and
may be more conserved across species than neural circuitry underlying complex social and
communication behaviors.

Author Manuscript

In this review, we outline recent advances in understanding the sensory processing
disruptions underpinning sensory features of ASD and FXS, focusing on the auditory
sensory domain. Rather than exhaustively reviewing the literature as others have done (e.g.
O’Connor, 2012; Orekhova and Stroganova, 2014), we highlight similarities and differences
between auditory sensory processing deficits in ASD and FXS to highlight aspects of their
shared and distinct pathophysiology. We then describe emerging evidence from rodent
models which sheds light on the possible neurobiological underpinnings of sensory deficits
in ASD, FXS and associated neurodevelopmental disorders.

2. Objective measurement of sensory processing

Author Manuscript

Auditory stimuli elicit stereotypical changes in electrical activity across the brain, which are
reproducibly detected by EEG and can be accompanied by predictable behavioral responses.
At a given location on the scalp (humans) or in the brain (rodents), changes in the electrical
field represent the summation of extracellular currents generated by postsynaptic
neurotransmission within neuronal networks (Creutzfeldt et al., 1966a,b), particularly those
in closer proximity to the electrode. Measurement of these electrical field changes by EEG
enables quantification of the amplitude, latency, frequency and power of neural oscillations,
including those induced by sensory stimulation. An analogous technique, MEG, measures
magnetic fields rather than electric fields in the brain and can also be used to quantify neural
electrical activity (Cohen, 1972). Sound-evoked changes in electrical activity occur
primarily in the brainstem/midbrain, thalamus, auditory cortex, amygdala, frontal cortex and
temporal cortex, regions which are involved in processing of auditory sensory information.
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Auditory processing advances through multiple stages, including pre-attentive stimulus
recognition, sensory perception, active attentional shifting, salience detection and taskdependent activity (Picton and Hillyard, 1974; Picton et al., 1974). Below we describe a
number of key experimental approaches which utilize EEG and/or behavioral measures in
order to investigate auditory processing and sensory filtering in ASD.
2.1. Event-related potentials (ERPs)

Author Manuscript
Author Manuscript
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Individual auditory stimuli each elicit a stereotypical pattern of voltage deflections in the
EEG signal, which are known as event-related potentials (ERPs) and can be reliably
quantified when responses to multiple auditory stimuli are averaged. For instance, the ERP
following simple auditory stimuli, such as sounds with a particular intensity, pitch and
duration, can be divided into discrete components. In humans, these components are termed
the P50, P200, P300, N100 and N200 and consist of positive deflections at 50, 200 and 300
ms post-stimulus and negative deflections at 100 and 200 ms post-stimulus (Fig. 1; Duncan
et al., 2009; Picton et al., 1974; Sutton et al., 1965). In rodents, analogous ERP components
are seen, but are termed the P1, P2, P3, N1 and N2. They arise with shorter latencies, with
P1, N1 and P2 components observed at approximately 20, 40 and 80 ms post-stimulus,
respectively (Fig. 1; Broberg et al., 2010; Maxwell et al., 2004; Siegel et al., 2003; Umbricht
et al., 2004; Witten et al., 2014). For consistency in this review, the rodent nomenclature will
be used in both species. Individual ERP components have been linked to a number of
aspects of sensory processing. The P1, N1 and P2 components are considered obligatory, in
that they are evoked regardless of task or attentive state (Picton and Hillyard, 1974). The P1
is thought to reflect sensory registration and pre-attentive stimulus processing, the N1
cortical activation and sensory perception, and the P2 salience detection and stimulus
evaluation. The P3, usually split into an earlier and more frontally located P3a and a later,
more posterior (parietal) P3b component, is an index of novelty and attentional orienting
elicited by infrequent or unpredictable elements introduced into otherwise predictable trains
of stimuli (Polich, 2007; Polich and Criado, 2006; Sutton et al., 1965). Importantly, ERPs
change across human and rodent postnatal development. In humans, there is evidence that
P1 amplitude decreases and N1 and P2 amplitudes increases with age, although these
changes differ depending on electrode location and vary between studies (Ponton et al.,
2000; Wunderlich and Cone-Wesson, 2006; Wunderlich et al., 2006). In particular, children
up to the age of 16 years display a prolonged, obligatory negative component which is less
discernible in adulthood (Ponton et al., 2000; Sussman et al., 2008; Wunderlich et al., 2006).
Latencies also change across development, with P1 and N1 latencies decreasing until
adulthood (Ponton et al., 2000). In rodents, the opposite developmental patterns in ERP
amplitude have been reported, with higher P1 amplitude and lower N1 and P2 amplitude in
juvenile mice (7 weeks old) relative to adults (12 weeks; Featherstone et al., 2014; Nagy et
al., 2015).
2.2. P1 (P50) suppression
Auditory stimuli not only induce ERPs and changes in neural oscillations, but also trigger
the engagement of filtering mechanisms that modify responses to subsequent stimuli. At a
neural level, this ‘gating’ phenomenon primarily involves the subconscious dampening of P1
responses to a second stimulus which occurs 0.5 s after the initial stimulus (Nagamoto et al.,
Neurosci Biobehav Rev. Author manuscript; available in PMC 2017 June 09.
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1991; Oranje et al., 2006). Abnormal P1 suppression involves a failure to diminish the P1
ERP response to the second click in a paired-click experimental paradigm (Freedman et al.,
1983).
2.3. Acoustic startle and pre-pulse inhibition of startle (PPI)
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Author Manuscript

A useful measure of general sensitivity to sensory auditory stimuli is the magnitude of the
startle response to an acoustic stimulus (Braff et al., 1992; Swerdlow et al., 1994). This
startle response can also be used to assess sensory filtering and sensorimotor gating. In a
behavioral test called pre-pulse inhibition of startle (PPI), a loud tone or noise (around 115
dB) is presented either alone or preceded by a quieter tone/noise of approximately 72–85
dB, 30–500 ms beforehand. Maximum PPI is generally occurring at around 120 ms in
humans (Braff et al., 1992; Graham, 1975), and at around 50 ms in rats. The extent of the
acoustic startle response (ASR) is measured either by EMG measurement of eye muscle
contraction (m. orbicularis oculi) in humans, or in rodents by the whole body twitch, sensed
by a motion sensitive platform (Valsamis and Schmid, 2011). Humans or animals with
normal PPI display strongly attenuated startle responses (by up to 70–90%) to the loud
acoustic stimulus if it is preceded by the quieter pre-pulse stimulus, whereas individuals with
diminished sensorimotor gating display less attenuation of startle responses by the pre-pulse
(Braff et al., 1992; Swerdlow et al., 1994). The neural circuitry mediating acoustic startle
responses is well-described and seems to be highly conserved (Schmid et al., 2014;
Swerdlow et al., 1999). Secondary auditory neurons in the cochlear nucleus (cochlear root in
mice and rats) innervate giant neurons in the caudal pontine reticular formation that directly
activate cranial and spinal motorneurons (Koch, 1999; Nodal and Lopez, 2003; Swerdlow et
al., 1999). PPI is thought to be mediated by a feed-forward inhibitory loop from the cochlear
nucleus to the inferior and superior colliculi and the pedunculopontine tegmental nucleus,
which in turn sends descending fibers to the startle mediating neurons in the reticular
formation (Fendt et al., 2001; Gomez-Nieto et al., 2014; Swerdlow and Geyer, 1993;
Yeomans et al., 2006).
2.4. Habituation, sensitization and refractory processes
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Trains of stimuli induce additional changes in EEG and behav-ior, which either reflect
refractory processes or the processes of habituation and sensitization. An example of
refractory processes is the dampening of the N1 amplitude, following repeated high
frequency stimulation: it may take up to 10 s for the N1 amplitude to fully recover after
initial stimulation (Budd et al., 1998; Davis et al., 1966; Oranje et al., 2006). Habituation is
the exponential decrement of a response to an initially novel stimulus that is presented
repeatedly over time at lower frequencies, and it is different from refractory processes.
Sensitization describes the opposite, an increment in response to the same stimulus over
time. Habituation and sensitization are thought to be independent processes, modulating the
same behavioural response in opposite ways (Groves and Thompson, 1970; Rankin et al.,
2009; Schmid et al., 2014). An overall sensitization is often found in the first 2–4 trials of a
block of startle-eliciting stimuli, followed by a gradual decline in responses (habituation) to
the remainder of presented trials (Aggernaes et al., 2010; Meincke et al., 2004). Habituation
(short-term) is assumed to be caused by synaptic mechanisms intrinsic to sensory pathways
(Davis et al., 1982; Leaton et al., 1985; Simons-Weidenmaier et al., 2006). Specifically,
Neurosci Biobehav Rev. Author manuscript; available in PMC 2017 June 09.
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short-term habituation of startle has been proposed to be caused by activity-induced synaptic
depression at the sensorimotor synapses in the pontine reticular formation, mediated by the
activation of voltage- and calcium dependent large conductance potassium channels, called
Maxi K, KCa1.1, or BK channels (Simons-Weidenmaier et al., 2006; Typlt et al., 2013b;
Weber et al., 2002). Sensitization and long-term habituation are caused through an extrinsic
modulation of the startle pathway by structures including the pedunculopontine tegmentum,
the cerebellar vermis, the amygdala and the bed nucleus of the stria terminalis (Davis et al.,
1997; Gonzalez-Lima et al., 1989; Koch, 1999; Leaton and Supple, 1986, 1991). The fact
that these circuits are relatively well described, highly preserved, and that they can be
studied in animal models, provides a unique opportunity for exploring potential mechanisms
underlying sensory filtering disruptions in ASD and FXS, as well as for identifying potential
drug targets to enhance sensory filtering.

Author Manuscript

2.5. Mismatch negativity (MMN)
Mismatch negativity (MMN) is another neural phenomenon reflecting underlying sensory
filtering which is revealed by studying EEG responses to trains of auditory stimuli in
humans (Näätänen et al., 2007) and rodents (Ehrlichman et al., 2008; Harms et al., 2014;
Nakamura et al., 2011; Siegel et al., 2003; Witten et al., 2014). Unlike P1 suppression, PPI
and habituation, which all dampen responses to less relevant stimuli, MMN involves the preattentive identification of more relevant stimuli among trains of less relevant ones. In the
context of repeated stimuli of consistent pitch, duration and intensity, a deviant tone will
elicit a negative deflection of the ERP at fronto-central and central electrodes (Näätänen et
al., 2007), with a latency dependent on the paradigm used. Because it reflects the differences
between evoked responses to two tones (standard and deviant), MMN is usually expressed as
a difference wave.

Author Manuscript

2.6. Neural oscillations
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Changes to the power and synchrony of neural oscillations also occur in response to auditory
stimulation. These changes occur in the context of, and can be influenced by, the patterns of
oscillations in resting state, where subjects are asked to think of nothing in particular. Both
at rest and following stimulation, information about neural oscillations across a range of
frequencies can be extracted from within the EEG signal using spectral decomposition
approaches such as fast Fourier transformation or wavelet analysis (Fig. 1). Neural
oscillations are important because, when divided into discrete frequency bands, they share
physiological properties. Delta frequency oscillations (1–3 Hz) are particularly relevant to
deep sleep, theta oscillations (4–7 Hz) to top-down cognitive control/memory, beta
oscillations (13–30 Hz) to task engagement/motor behavior and gamma oscillations (30–80
Hz) to sensory and cognitive inhibition. In addition, changes in phase synchronization of the
alpha frequency band (8–12 Hz) are thought to generate some components of the ERP, such
as P1 and N2 (Gruber et al., 2005). Neural oscillations in rodents change across postnatal
development, with increases in baseline power (Featherstone et al., 2014) and induced power
(time-locked but not phase-locked to stimulus; Nagy et al., 2015) occurring during
adolescence.
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3. Sensory processing in individuals with ASD and FXS
3.1. ERPs

Author Manuscript
Author Manuscript

Abnormal auditory ERPs, consistent with impaired sensory processing, have been revealed
by EEG in individuals with ASD. Decreased amplitude of the P1 peak at fronto-central
electrodes has been described using both a classical P1 suppression paradigm in children
aged 7–12 years with Asperger’s syndrome (Madsen et al., 2015) and in children aged 7–12
years with ASD by presenting speech and non-speech sounds (Lepisto et al., 2005). This
latter finding was replicated in a more recent study which reported decreased amplitude of a
later component of the P1 in the central region in children aged 3–8 years with ASD
(Stroganova et al., 2013). Increased variability of P1 amplitude and latency between trials
may also occur in individuals with ASD (Milne, 2011). In a MEG study, increased latency of
the M50 (equivalent to ERP P1) predicted language deficits in ASD (Oram Cardy et al.,
2008). Decreased amplitude of the N1 component of the ERP has been observed in children
with ASD aged 4–16 years (Bruneau et al., 1999; Gandal et al., 2010; Seri et al., 1999).
Consistent with a role for early sensory processing abnormalities underpinning symptoms in
ASD, a negative correlation between N1 amplitude (N1a at temporal electrodes and N1b at
fronto-central electrodes) and autism symptom severity in children and adolescents 6–17
years has been reported (Brandwein et al., 2015). Increased N1 latency in ASD has been
reported in some studies (Gage et al., 2003; Gandal et al., 2010; Korpilahti et al., 2007;
Roberts et al., 2010) but not others (Bruneau et al., 1999; Ceponiene et al., 2003; Madsen et
al., 2015). This may be explained in part by differences in mean age of subjects between
studies, given that two studies using MEG have shown that normal age-related decreases in
M100 between 8 and 16 years were absent in ASD individuals (Gage et al., 2003; Roberts et
al., 2010). Such developmental differences may make detection of N1 latency differences in
ASD more difficult in cohorts of younger children with a mean age <8 years (Bruneau et al.,
1999; Ceponiene et al., 2003; Madsen et al., 2015) than older children with a mean age >9
years (Gage et al., 2003; Gandal et al., 2010; Korpilahti et al., 2007; Roberts et al., 2010). In
addition to decreased amplitude of N1, decreased amplitude of N2 fronto-centrally for nonspeech sounds has also been described (Lepisto et al., 2005). There is evidence that sensory
processing deficits may be identifiable prior to ASD diagnosis. Increased P1 amplitude
during standard repetitive speech stimuli in infants at high risk of ASD relative to children at
low risk has been described (Seery et al., 2014), as has a failure of normal later-alization of
ERPs during development in infants at high risk (Seery et al., 2013). These findings suggest
a possible role for altered sensory processing as a risk factor for ASD and/or an early
emerging symptom of the disorders.
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Abnormalities of attentional orienting, indexed by P3 have also been investigated in ASD.
The P3 consists of the P3a and P3b components, which are both elicited by infrequent or
unpredictable elements introduced into otherwise predictable trains of stimuli. The P3a
component occurs at 250–280 ms, and is present when infrequent or unpredictable shifts
occur during a train of otherwise predictable stimuli regardless of where the participant is
asked to direct his or her attention (Hruby and Marsalek, 2003; Squires et al., 1975). The
P3a is therefore often described as a ‘novelty detector’ (Comerchero and Polich, 1999;
Hruby and Marsalek, 2003). The P3b is also evoked by oddball tasks, and is observed at
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250–500 ms (Polich, 2007). However, the amplitude of the P3b is dependent upon how
improbable a stimulus is, with more improbable stimuli resulting in larger amplitude
responses (Polich, 2007; Sutton et al., 1965). Both are elicited by infrequent or unpredictable
elements introduced into otherwise predictable trains of stimuli (Hruby and Marsalek, 2003;
Squires et al., 1975). Age dependent abnormalities of the P3a have been described in ASD,
with increased P3a amplitude to pure tone deviants evident in childhood (less than 8 years of
age) but decreased P3a amplitude evident in young adulthood in a small study (Ferri et al.,
2003). Decreased P3a amplitude has been observed at younger ages (mean age 9 years) for
vowel sound and speech-like frequency deviants in children with ASD and Asperger’s
syndrome (Ceponiene et al., 2003; Lepisto et al., 2005, 2006). Impairment of P3a in ASD is
consistent with evidence of attentional deficits in ASD (for review see Orekhova and
Stroganova, 2014), and suggests a common underpinning neurobiological mechanism.
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Abnormal auditory ERPs have also been described in FXS. The published work is primarily
on temporal and amplitude properties of the auditory ERPs (Knoth and Lippe, 2012;
Rotschafer and Razak, 2014). A consistent observation across studies is that the N1
component has larger average amplitude and shows reduced habituation to repeated sounds
in humans with FXS compared to control subjects (Castrén et al., 2003; Ethridge et al.,
2016; Rojas et al., 2001; St Clair et al., 1987; Van der Molen et al., 2012a,b). A study using
MEG also revealed enlargement and reduced latency of the N100 m (the MEG equivalent of
the N1 in EEG) in adults with FXS (Rojas et al., 2001). Interestingly, the direction of N1
amplitude and latency changes in FXS is opposite that of ASD described above. Typically,
FXS-related N1 enhancement is accompanied by P2 enhancement (Castrén et al., 2003; St
Clair et al., 1987; Van der Molen et al., 2012a,b). Treatment with candidate
pharmacotherapy minocycline can decrease N1 and P2 amplitudes in individuals with FXS
(Schneider et al., 2013), suggesting that auditory ERP abnormalities can be used as outcome
measures in drug treatment in human studies. Since both N1 and P2 components stem from
temporal lobe activity, the altered N1 and P2 amplitudes are consistent with structural
deficits in temporal lobe regions in humans with FXS, implicating this region in some of the
behavioral abnormalities associated with FXS. These structural deficits include decreased
size of superior temporal gyrus (Reiss et al., 1994), and white matter enlargement localized
specifically to the temporal lobe (Hazlett et al., 2012). Additionally, fMRI research shows
that the superior temporal gyrus, along with the medial frontal gyrus, middle temporal gyrus,
cerebellum, and pons display higher levels of activation in individuals with FXS, consistent
with the larger N1 component (Hall et al., 2009). Enhancement of the P2 component also
suggests abnormal activation of the mesencephalic reticular activating system. Structures
linked to P2 generation are also responsible for early auditory processing. Alteration of P2associated structures may create an incorrect memory trace of the target stimulus, which
may decrease performance on stimulus detection tasks (Näätänen et al., 2011, 2007).
The amplitude of the P3 component is also consistently reduced in humans with FXS (St
Clair et al., 1987; Van der Molen et al., 2012a,b). Specifically, Van der Molen et al.
(2012b,a) revealed reduced P3a and P3b components in individuals with FXS. Decreased
P3b amplitude, specifically, may reflect a failure to identify a stimulus as improbable
(Sutton et al., 1965), possibly resulting from improper stimulus representation at lower
levels of processing, or from short term memory impairments (Polich, 2007).
Neurosci Biobehav Rev. Author manuscript; available in PMC 2017 June 09.
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In summary, various components of the auditory ERP are altered in FXS, with the N1/P2
changes predicting reduced habituation to a continuous acoustic environment. This may
underlie the hypersensitivity phenotype observed behaviorally in humans with FXS. The
changes in the longer latency components indicate improper memory trace formation that
may result in reduced auditory change detection. Whether such deficits are present in early
development has not been directly tested. However, if present, these deficits will leave an
indelible mark on maturation of language and cognitive functions.
3.2. P1 (P50) suppression
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Despite the phenotypic variation within the autistic spectrum, abnormal perception and
processing of sensory information appears to be a shared phenomenon. Adequate processing
of sounds and appropriate attention oriented towards them are considered prerequisites for
accurate higher order processing. Similar to individuals with schizophrenia, it has been
suggested that deficient inhibitory control of sensory stimuli in ASD may cause sensory
overload and disruption of higher order processing, leading to avoidance of external
stimulation altogether (Kootz et al., 1982). P1 suppression is a valuable index of inhibitory
control of sensory stimuli, yet in ASD, research on P1 suppression has been sparse. There is
some evidence for reduced P1 suppression in very young (3–8 years) autistic children with
intellectual disability (IQ < 72), but this seemed to improve with age (Orekhova et al., 2008).
Studies on older ASD subjects without intellectual disability showed comparable P1
suppression with typically developing children (Kemner et al., 2002), similar to that
observed in the PDD-NOS subgroup Multiple Complex Developmental Disorder (MCDD)
(Oranje et al., 2013b). Neither were P1 suppression deficits found in a study on adult males
with ASD (Magnee et al., 2009). Healthy P1 suppression was also found in two recent
studies on 8–12 year old children with ASD (Madsen et al., 2015), although a subpopulation
of these children (those with Asperger’s syndrome) showed attenuated P1 amplitude
(Madsen et al., 2015). In summary, there is currently not much evidence for a P1
suppression deficit in autism, although on amplitude level the P1 ERP appears smaller in
children with Asperger’s syndrome. Future studies should include larger sample sizes not
only in order to increase power, but also to allow grouping based on sub-diagnoses.
Although inhibitory control of auditory sensory processing is also of interest in FXS, P1
suppression has not been investigated in FXS to our knowledge.
3.3. Acoustic startle and PPI
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Acoustic startle reactivity has been used in ASD and FXS research as an objective measure
of sensitivity to auditory stimulation. Increased startle magnitude in ASD, indicating higher
auditory sensitivity, has been reported in both adults (Kohl et al., 2014) and children
(Chamberlain et al., 2013; Takahashi et al., 2016). Other studies, however, have not found a
general increase of startle magnitude in subjects with autism (Bernier et al., 2005;
McAlonan et al., 2002; Salmond et al., 2003; Sterling et al., 2013; Yuhas et al., 2011).
Because startle reactivity in individuals with ASD may be influenced by their level of
functioning, these divergent results may have occurred in part due to differences in the
severity and/or range of ASD symptoms in different cohorts. In a study which took into
account ASD symptom severity, increased startle magnitude was only seen in higher
functioning individuals (Kohl et al., 2014). Choice of auditory stimulus in the experimental
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paradigms used may also have influenced the ability of some studies to detect startle
abnormalities, since it has been shown that adult ASD subjects exhibit increased startle
responses to pleasant stimuli, but not to neutral or unpleasant stimuli (Dichter et al., 2010;
Wilbarger et al., 2009). Alongside possible increases in startle magnitude, increases in startle
latency have also been reported in ASD (Ornitz et al., 1993; Takahashi et al., 2016; Yuhas et
al., 2011). Like startle mag nitude, startle latency may be influenced by the severity of ASD
symptoms. Whereas high-functioning individuals with ASD may display greater startle
magnitude, they have been reported to display no change in startle latency (Bernier et al.,
2005). Normal startle magnitude and latency have been reported in FXS (Frankland et al.,
2004; Yuhas et al., 2011). Overall, although these studies of acoustic startle in ASD are
consistent with increased sensitivity to auditory stimulation and altered sensory processing,
further work is required to clarify the influence of stimulus valence and other experimental
parameters on startle measurements. A greater understanding of whether startle reactivity
correlates with specific ASD symptom profiles will also shed light on the translational and
diagnostic utility of these measures.
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PPI is an additional startle measure which has been investigated in ASD and FXS and takes
advantage of the acoustic startle response to quantify sensorimotor gating. Reports on
disruptions of PPI in ASD and FXS have not been consistent to date. For ASD, many studies
on both adults as well as children with autism found no change in PPI (Kohl et al., 2014;
Oranje et al., 2013b; Ornitz et al., 1993; Takahashi et al., 2016; Yuhas et al., 2011), while
others report reduced PPI at least in adults (McAlonan et al., 2002; Perry et al., 2007). One
study found slightly higher PPI levels at 76 dB pre-pulses in 8–12 year old children with
autism (Madsen et al., 2014). Although it is possible that experimental variability or cohort
heterogeneity is preventing reliable detection of subtle PPI deficits in ASD, it is currently
not possible to conclude that altered PPI is a robust feature of ASD.
In contrast, individuals with FXS have robustly disrupted PPI compared to normal controls
and individuals with ASD only (Frankland et al., 2004; Yuhas et al., 2011). Interestingly,
although PPI deficits have been identified in FXS subjects regardless of their comorbid ASD
diagnosis, they have also been correlated with the severity of autistic traits (Frankland et al.,
2004), repetitive behavior (Perry et al., 2007) and several subscales of Social
Responsiveness Scale and the Strength and Difficulties Questionnaire (Takahashi et al.,
2016). This suggests that the PPI deficits in FXS reflect pathological sensory processing
which also underpins the emergence of autism-related phenotypes in FXS. It also suggests
that, although abnormal PPI has not been conclusively demonstrated in ASD, it may still be
an informative indicator of abnormal sensorimotor gating in ASD and related disorders.
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3.4. Habituation
Baseline startle reactivity is greatly influenced by short-term and long-term habituation
(Valsamis and Schmid, 2011), which occurs independently of PPI and has been investigated
in ASD, but not (to our knowledge) in FXS. Habituation is a form of sensory filtering and
there is evidence that short-term habituation is slower at least in subpopulations of autistic
individuals (Ornitz et al., 1993; Perry et al., 2007). Other studies which did not find
differences in short-term habituation levels in ASD (Kohl et al., 2014; McAlonan et al.,
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2002; Takahashi et al., 2016) may not have been well equipped to reveal any differences in
the time scale of habituation, since blocks of responses before and after PPI testing were
compared. Both short-term and long-term habituation deserve further investigation in
children and adults with ASD and FXS.
3.5. MMN
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MMN and other changes elicited by deviant auditory stimuli have also been investigated in
ASD and FXS, in order to assess the integrity of pre-attentive auditory change detection
mechanisms. Reports on MMN in ASD are highly inconsistent. Some studies report larger
MMN amplitude in children with ASD (Ferri et al., 2003; Kujala, 2007; Lepisto et al., 2005,
2006), whereas others report smaller (Abdeltawwab and Baz, 2015; Ludlow et al., 2014) or
equal amplitudes compared to typically developing children (Dunn et al., 2008; JanssonVerkasalo et al., 2003; Roberts et al., 2011; Seri et al., 1999; Weismuller et al., 2015). Given
the scope of this review, only MMN amplitude data are considered here. For information on
MMN latency we refer the reader to other recent reviews (Kujala, 2007; Näätänen et al.,
2011; Orekhova and Stroganova, 2014; Seri et al., 2007).
One likely contributor to disparities in the MMN studies described above is experimental
differences between MMN paradigms, particularly at the level of the auditory stimuli used.
Therefore, when considering here whether conclusions can be drawn from the MMN
literature to date, we have subdivided MMN studies based on a) whether auditory stimuli
consisted of pure tones (i.e. non speech-like) or more complicated, speech-like stimuli, and
b) whether frequency or duration deviants were used.
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In pure tone MMN paradigms, children with ASD have been reported to show either less
(Abdeltawwab and Baz, 2015; Dunn et al., 2008), more (Ferri et al., 2003) or normal MMN
to frequency deviants (Jansson-Verkasalo et al., 2003; Weismuller et al., 2015). Attention
may impact consistency of findings with pure tone frequency deviants, given that one study
reported reduced MMN amplitude to changes in frequency of pure tones in children with
ASD in unattended conditions, but equal amplitudes in attended conditions (Dunn et al.,
2008). Although the above mentioned studies were typically conducted in unattended
conditions, the nature of the distractor stimulus differed substantially between studies (e.g.
animated silent movie, picture book, etc.), and may have had different salience for
individuals of different ages within each study. Electrode placement may also play a role,
given that in some work, MMN amplitude deficits to pure tone frequency deviants could
only be detected in children with ASD when the topography of the electrodes was taken into
account, since maximal MMN amplitude was observed at the frontal Fz electrode in controls
and more posterior C3/4 electrodes in individuals with ASD (Gomot et al., 2002). While
some studies only record at Fz (Abdeltawwab and Baz, 2015; Seri et al., 1999), others use
the International 10–20 System to record at multiple sites (Weismuller et al., 2015).
Inconsistent results found with pure tone paradigms may also have been caused by
differences in composition of ASD cohorts. Overall, the data seems to suggest a decrease in
MMN to pure tone deviants, although further work is required to confirm this effect.
In MMN paradigms employing speech-like stimuli, a disparate picture is also seen. There is
some evidence indicating that MMN to complex speech-like deviants or vowel/word change
Neurosci Biobehav Rev. Author manuscript; available in PMC 2017 June 09.

Sinclair et al.

Page 12

Author Manuscript
Author Manuscript

is reduced in children with ASD compared to typically developing children (Kuhl et al.,
2005; Kujala et al., 2010; Ludlow et al., 2014). However, other studies have not reported
such diagnostic differences (Ceponiene et al., 2003; Kasai et al., 2005; Oram Cardy et al.,
2005; Weismuller et al., 2015), or have reported enhanced MMN amplitude to frequency
deviants or affective prosody in ASD or Asperger’s syndrome compared to typically
developing children (Korpilahti et al., 2007; Lepisto et al., 2005, 2006). In the studies of
Lepisto and colleagues, increased MMN in ASD and Asperger’s syndrome was not found at
the usual frontal electrodes (Fz) but rather only at parietal electrodes, possibly reflecting the
MMN in primary auditory cortex and reinforcing that differences in the locations of
recording electrodes may impact the ability to detect MMN abnormalities in ASD. In
circumstances where there may be increased MMN to frequency deviants in ASD, this may
not be accompanied by concordant increases for duration deviants since studies reporting
increased MMN to frequency deviants in ASD also report normal (Lepisto et al., 2005) or
decreased (Lepisto et al., 2006) MMN to duration deviants.
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Despite the disparity of MMN findings in both pure tone and speech-like stimulus
paradigms, there are two areas in which a more consistent picture is emerging. Firstly,
studies employing a range of paradigms have reported that normal lateralization of MMN is
diminished or absent in ASD subjects compared to healthy controls (Jansson-Verkasalo et
al., 2003; Korpilahti et al., 2007; Kuhl et al., 2005; Lepisto et al., 2006; Weismuller et al.,
2015). Unfortunately, due to the placement of electrodes, many studies are not designed to
compare MMN in both hemispheres. Secondly, multiple studies have reported a relationship
between MMN and measures of ASD symptom severity (such as sensory profiles, auditory
preference etc.). These studies, which found decreased MMN in ASD, reported that greater
MMN deficits were associated with increased sensory sensitivity (Ludlow et al., 2014),
decreased auditory preference for speech (Kuhl et al., 2005) and increased CARS score
(Abdeltawwab and Baz, 2015). These observations suggest that, in some cohorts of
individuals with ASD, impairment of sensory filtering and auditory change detection are
associated with, and may underlie, sensory hypersensitivity and other autism-related
phenotypes.
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In summary, the results of studies on MMN in ASD are inconsistent, although there seems to
be some evidence for deficient MMN amplitudes in children with ASD and FXS. It is
challenging to determine which factors contribute most to this variability, given that studies
differ in the nature of auditory stimulus and deviant, EEG recording locations, ages of
subjects and severity of subjects’ ASD symptoms and comorbidities. Future studies should
include larger sample sizes, so that comorbidity and levels of anxiety can be taken into
account and the ASD cohort split in meaningful (DSM-V based) subcategories.
Furthermore, studies should use standardized paradigms for measurements and data
analyses, or at least report on a standard set of electrodes (in combination with interesting
results from other electrodes), in order to facilitate comparisons of results across studies.
In FXS, MMN and other changes elicited by deviant auditory stimuli have also been
investigated. In addition to the abnormally high amplitude, an inability of the N1 amplitude
to distinguish between a standard tone of high probability of occurrence and an ‘oddball’
tone of low probability of occurrence has been described in FXS (Van der Molen et al.,
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2012a,b). In control subjects, the average N1 amplitude was smaller for the standard tone
compared to the oddball tone, while in individuals with FXS, the standard and oddball tones
elicited similar N1 responses (Van der Molen et al., 2012a,b). Enlargement of the N2b wave
(Van der Molen et al., 2012a,b) and increased N2 latency (St Clair et al., 1987; Van der
Molen et al., 2012a) have also been seen in individuals with FXS. However, despite a
general increase in N2 amplitude, decreased MMN to pure tone frequency deviants has been
reported in individuals with FXS (Van der Molen et al., 2012b). As was observed in ASD
(Gomot et al., 2002), the maximal MMN amplitude was identified at different electrodes in
FXS and control individuals (Van der Molen et al., 2012b). Given the scarcity of studies of
MMN in FXS, further work is required to confirm increased MMN and altered sensory
filtering in FXS.
3.6. Baseline and evoked changes in neural oscillations
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Abnormal ‘baseline’ neural oscillations have been reported in ASD. In the resting state,
increased power of low frequency (delta and theta) and high frequency (beta, gamma)
oscillations, alongside decreased power of mid-range (alpha) oscillations, have been
described in children and adults with ASD (Machado et al., 2013; Orekhova et al., 2007,
2008; van Diessen et al., 2014), (reviewed in Wang et al., 2013). In children aged 3–8 years
with ASD, increased baseline gamma was negatively correlated with P1 suppression, such
that increased baseline gamma was associated with greater impairment of P1 suppression
(Orekhova et al., 2008).
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Altered neural oscillatory responses to sensory stimulation have also been reported in ASD.
Increased gamma power and decreased phase-locking of gamma oscillations in response to
auditory stimuli have been described in individuals with ASD and/or their parents, as
detected by MEG (McFadden et al., 2012; Rojas et al., 2011, 2008). Abnormal synchrony of
oscillations across the theta and gamma bands in response to speech in ASD has also been
described (Jochaut et al., 2015). The observed failure of theta activity in auditory cortex to
downregulate gamma oscillations in response to speech was correlated with verbal
impairment and general autism symptoms (Jochaut et al., 2015). These few abovementioned studies are consistent with other studies using visual cues (such as faces) that
have also revealed abnormal evoked oscillations in ASD, particularly in the gamma
frequency range (Grice et al., 2001; Keehn et al., 2015; Wright et al., 2012). Overall, studies
of baseline and evoked neural oscillations in ASD support a role for impaired resting state
and auditory-evoked cortical activity in sensory processing deficits in ASD.
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Although patterns of neural oscillations have not been extensively investigated In FXS, two
studies have indicated that resting (baseline) power of neural oscillations, and underlying
functional connectivity, are impaired in FXS. As observed in ASD, increased baseline theta
(4–8 Hz) power occur has been described in FXS (Van der Molen and Van der Molen, 2013).
Also consistent with ASD, decreased alpha power (in this case, in the upper alpha 10–12 Hz
range) is also seen in individuals with FXS (Van der Molen and Van der Molen, 2013). In
that study, oscillations in other frequency bands (beta 13–30 Hz and gamma 30–80 Hz) were
not investigated. Finally, functional connectivity computed from the resting EEG phase lag
index is reportedly altered in FXS, with increased resting theta functional connectivity and
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decreased resting alpha and beta functional connectivity mirroring diagnostic differences in
baseline neural oscillations (van der Molen et al., 2014). These abnormalities in baseline
neural oscillations suggests that, as in ASD, impaired resting state cortical activity may play
a role in altered sensory processing and cognitive function in FXS.
A summary of auditory sensory processing abnormalities in ASD and FXS is provided in
Table 1.

4. Sensory processing in rodent models relevant to FXS and ASD
4.1. Animal models relevant to FXS
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The fragile X mental retardation 1 (Fmr1) knock out (KO) mouse is a pre-clinical animal
model to study the pathophysiology underlying FXS with well-characterized construct and
face validity (Bakker et al., 1994). Fmr1 KO mice lack the Fragile X Mental Retardation
Protein (FMRP) and show several FXS-and ASD-like symptoms (Bernardet and Crusio,
2006), including social impairments (Spencer et al., 2005), repetitive behaviors (Crawley,
2004, 2007), heightened anxiety (Bilousova et al., 2009), hyperactivity that may be related
to increased arousal in a novel environment (Kramvis et al., 2013) and altered ultrasonic
vocalization communication by both pups and adults (Rotschafer et al., 2012; Roy et al.,
2012). Physical alterations seen in humans such as macro-orchidism are also seen in the
Fmr1 KO mouse (Lachiewicz and Dawson, 1994; Sidhu et al., 2014). One caveat to consider
in examining predictive validity in the mouse model include the fact that in the Fmr1 KO
mouse, the protein FMRP is virtually absent, whereas in humans with FXS, the number of
CGG repeats influences FMRP levels and the range of resulting deficits. It is also important
to note that there are mouse strain specific differences that interfere with different measures
(Bernardet and Crusio, 2006). Nevertheless, the Fmr1 KO mouse recapitulates several FXSlike symptoms and is a commonly used pre-clinical model (Kooy et al., 1996). Most
encouragingly, Fmr1 KO mice also exhibit sensory system deficits. These deficits have been
measured in terms of increased susceptibility to audiogenic seizures, increased response of
sensory cortex to stimuli (Rotschafer and Razak, 2014; Zhang et al., 2014), increased UP
states in sensory cortex (Hays et al., 2011), increased spontaneous and correlated activity in
sensory cortex (Goncalves et al., 2013) and reduced habituation of sensory stimulus evoked
responses (Lovelace et al., 2016). Some of these deficits may arise due to abnormal critical
period plasticity during development (Contractor et al., 2015; Kim et al., 2013).
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Prominent deficits appear consistently in auditory sensitivity. FMRP is expressed across
multiple levels of the auditory neuraxis (Wang et al., 2014). Genetic removal of FMRP in the
mouse model results in increased propensity for audiogenic seizures, suggesting
hypersensitive auditory responses. In Fmr1 KO mice, auditory stimuli with sound levels
>100 dB SPL can cause a period of wild running, tonic/clonic seizing, and death (Chen and
Toth, 2001; Musumeci et al., 2000, 2007). Reintroduction of FMRP to Fmr1 KO mice
significantly reduced audiogenic seizure susceptibility (Musumeci et al., 2007). In terms of
acoustic startle responses and their modulations, Fmr1 KO mice seemed to have an opposite
phenotype to what was found in human studies: they display lower startle responses, and
higher PPI (Chen and Toth, 2001; Frankland et al., 2004; Olmos-Serrano et al., 2011; Yun et
al., 2006), although one group found PPI to be normal in these mice PPI (Uutela et al.,
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2012). However, Nielsen et al. (2002) showed that startle responses were decreased only at
higher amplitude stimuli, and actually increased at lower startle stimulus amplitudes,
resembling individuals with FXS in their increased sensitivity to low intensity auditory
stimuli. It would be interesting to see if PPI in Fmr1 KO mice also depends on stimuli
intensity and is increased at lower prepulse/pulse combinations.
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Recent studies have revealed an exciting potential connection between the molecular
alterations in FXS and startle habituation mechanisms: it has been shown that FMRP
directly interacts with synaptic BK channels, which in turn have been shown to be crucial
for short-term habituation (Deng et al., 2013; Hebert et al., 2014; Typlt et al., 2013b; Zhang
et al., 2014). Unfortunately, startle habituation is not well studied in humans with FXS or
Fmr1 ko mice, however, the allosteric BK channel activator BMS-204352 was shown to
reverse behavioural and cellular FXS symptoms in Fmr1 ko mice (Hebert et al., 2014),
highlighting the potential of studying sensory filtering mechanisms in animal models for
developing pharmaceutical treatments. More potent and specific BK channels modulators
are currently developed and in clinical trials (mostly for stroke and/or epilepsy treatment),
however, the abundant BK channel expression in the periphery, e.g. in the myocardium,
vasculature, and bladder, pose a major challenge.
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To address the mechanisms that may underlie the differences in auditory processing in FXS,
(Rotschafer and Razak, 2014) performed in vivo extracellular single neuron recordings from
the auditory cortex of the Fmr1 ko and wildtype (WT) mice. Fmr1 ko mouse cortex showed
four main processing deficits in the primary auditory cortex (A1) at the single neuron level:
(1) Hyper-excitability: cortical neurons in KO mice respond with more action potentials to
tones than WT neurons. The increased response was due to prolonged spiking indicating that
the KO neurons failed to shut down their responses after sound offset. This may underlie the
hyper-excitability phenotype in both humans with FXS and the mouse model (2) Increased
variability: the first spike latency in response to tones in KO mice neurons was more variable
indicating that the neurons were not providing consistent information for repetitions of the
same sound. (3) Broader receptive fields: the excitatory frequency tuning curves are broader
in the KO mice neurons. This indicates that for a given tone, more neurons will be activated.
This may explain the larger amplitude and more widespread activation of the auditory cortex
in FXS. (4) Reduced spectrotemporal selectivity: reduction in selectivity for the rate of
frequency modulated (FM) sweeps. This was because the KO neurons responded better to
much shorter duration sounds and faster changes in frequency that WT neurons. The robust
responses to sounds as short as <3 ms in KO neurons is typically not seen in WT neurons
and indicates that the KO neurons have a different temporal integration window and are
easier to stimulate than WT neurons.
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The in vivo single neuron electrophysiology data suggest deficits in spectral and temporal
processing in auditory cortex of KO mice that may relate to auditory deficits in humans with
FXS. Preliminary data based on auditory ERPs from the Fmr1 KO mouse cortex suggests a
more directly translation relevant phenotype in the mouse (Lovelace et al., 2016). Auditory
ERPs were measured using electrodes placed between 200 and 400 μm deep in the primary
auditory cortex of anesthetized Fmr1 KO and WT mice. Repeated presentation of a sound
stimulus (tones or noise) at various repetition rates (0.25–5 Hz) showed a robust reduction in
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habituation of the N1 component for repetition rates faster than 1 Hz in the Fmr1 KO mice.
The similar habituation deficit in auditory ERP habituation in humans and mice provides a
useful translation relevant functional marker to include in drug development for FXS. The
deficit in early sensory processing will also allow an examination of circuit and cellular
deficits (Gibson et al., 2008; Hays et al., 2011; Selby et al., 2007) that may be more tractable
than complex social behaviors and importantly conserved across species.
4.2. Animal models of possible etiologic factors in idiopathic ASD
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There is a huge range of transgenic mouse lines which model possible etiologic factors in
ASD and show analogies to the diagnostic symptoms of autism, including low social
interactions, reduced vocalizations in social settings, and high levels of repetitive selfgrooming. Table 2 lists relevant rodent strains and their respective ERP, MMN, startle
reactivity, PPI and neural oscillation abnormalities. Most of them show distinct alterations in
startle reactivity and/or PPI, which has been the focus of sensory processing characterization
in rodent models of ASD even though findings in humans with ASD are not consistent. In
contrast, ERPs, MMN, habituation and neural oscillations have been less commonly
assessed even though abnormalities of these measures in ASD are more replicable. Some
strains have been studied further for sensory processing abnormalities. For example,
contactin associated like protein 2 (Cntnap2) was first associated with Specific Language
Impairment (SLI) and has been linked to ASD. Cntnap2 homozygous null mice have shown
distinct alterations in auditory processing, i.e. in silent gap detection and pitch
discrimination (Rendall et al., 2015; Truong et al., 2015), and increased PPI (Brunner et al.,
2015). Of special interest is also the BK-channel knock-out mouse that shows disruptions in
short-term habituation of startle, along with repetitive self-grooming, mild PPI deficits, and
specific cognitive deficits (Typlt et al., 2013a,b). As mentioned above, BK channels are
crucial for short-term habituation, Fragile x mental retardation protein directly interacts with
synaptic BK channels (Deng et al., 2013; Hebert et al., 2014; Typlt et al., 2013b; Zhang et
al., 2014).
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Apart from genetic factors, maternal infections and exposure to valproate (VPA) during
pregnancy have been shown to greatly increase the risk for a child to develop autism. This
has led to the establishment of respective animal models. One of the best established ASD
models are intraperitoneal injections of 600 mg VPA at gestation day 12.5 in rats which
causes cardinal symptoms of ASD in the offspring (reviewed by Roullet et al., 2013).
Prenatal VPA treatment increases ERP N1 latency, decreases evoked gamma power and
decreases gamma phase locking (Gandal et al., 2010). It also reduces PPI in young rodents,
and to a lesser extent in adult rodents, while startle response amplitudes seem to be
unchanged (Schneider and Przewlocki, 2005; Schneider et al., 2006). Postnatal treatment
with 150 mg/kg VPA for six days reduces startle responses and impairs PPI in adult rats as
well (Reynolds et al., 2012). Interestingly, offspring of a male rat of advanced paternal age
(another risk factor for ASD identified in humans; Sandin et al., 2015) has also shown to
reduce startle reactivity and impair PPI (Milekic et al., 2015).
Maternal infections during pregnancy can be mimicked by injections of Lipopolysaccharides
(LPS) or Polyinosinic:polycytidylic acid (poly-IC). Prenatal LPS seems to increase startle
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reactivity at least in male offspring (Foley et al., 2015) and induces PPI deficits (Fortier et
al., 2007). Prenatal immune challenge by poly-IC leads to either less startle reactivity in rats
(Vorhees et al., 2015), or unchanged startle responses (Howland et al., 2012; Meyer et al.,
2008), but consistent with VPA models disrupts PPI in the offspring (Howland et al., 2012;
Meyer et al., 2008; Vorhees et al., 2015). Likewise, influenza virus injection at gestational
day 9.5 in mice leads to PPI deficits in adolescence (Shi et al., 2003).
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In conclusion, a range of different rodent models show some or all of the cardinal symptoms
of ASD, have face and/or construct validity, and show changes in startle reactivity and/or
PPI, indicating that sensory processing and sensory filtering is affected in these models.
Changes in startle responsiveness, habituation, and PPI depend greatly on the specific
parameters used, such as stimulus intensities and temporal properties. Unfortunately,
parameters vary substantially between studies. This might explain some of the variability in
startle modulations between different animal models. Like in human studies, some
variability might be inherent, due to the fact that different perturbations all lead to autistic
symptoms, while having different (even opposite) effects on sensory processing and sensory
filtering. Nevertheless, these animal models provide the unique opportunity to study cellular
and molecular mechanisms underlying the emergence of ASD and FXS symptoms.
4.3. Animal models of circuit changes that recapitulate ASD phenotypes
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Abnormal ERPs and neural oscillations, akin to deficits in ASD, are evident in a number of
rodent models of disrupted excitatory/inhibitory balance. Three such models, of constitutive
pan NMDA receptor hypofunction (Gandal et al., 2012a,b), cell-type specific NMDA
receptor ablation (Saunders et al., 2013) and transient NMDA receptor blockade (Saunders
et al., 2012), have shed light on mechanisms which may underlie the emergence of
electrophysiological and sensory processing deficits in ASD (Table 3).

Author Manuscript

Mice which have widespread, constitutively decreased expression of the obligatory GluN1
subunit of the NMDA receptor (GluN1neo−/−) display disrupted sensory processing and other
ASD relevant phenotypes. In the hippocampus, GluN1neo−/− mice exhibit delayed N1
latency, increased baseline gamma power, decreased auditory evoked gamma power and
decreased evoked gamma phase synchrony/inter-trial coherence (ITC) (Gandal et al.,
2012a,b; Halene et al., 2009), reminiscent of ASD (Bruneau et al., 1999; Gage et al., 2003;
Gandal et al., 2010; Machado et al., 2013; Orekhova et al., 2007, 2008; van Diessen et al.,
2014). ERP and gamma frequency abnormalities were accompanied by decreased PPI,
decreased premating ultrasonic vocalizations, diminished social preference, decreased
anxiety-like behavior and stereotyped behaviors (Gandal et al., 2012a,b; Halene et al., 2009).
A number of other impairments in GluN1neo−/− mice point to generalized neuronal hyperexcitability due to dysfunction of fast spiking par-valbumin (PV)-positive interneurons as the
central pathology in these mice, consistent with a number of other ASD mouse models
including the neuroligin-3 R451C, PDGFR-β KO and prenatal VPA models which also show
PV interneuron pathology (Gogolla et al., 2009; Nakamura et al., 2015). This is also similar
to the PV neuron dysfunction observed in the cortex of Fmr1 KO mice (Gibson et al., 2008;
Hays et al., 2011). Impairments in the GluN1neo−/− mice included decreased protein
expression of the GABA-A receptor and parvalbumin, and increased pyramidal neuron
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intrinsic excitability (Gandal et al., 2012b). Abnormal PV protein expression has also been
observed in ASD but in contrast to GluN1neo−/− mice, PV immunoreactivity was increased
in postmortem ASD tissue (Lawrence et al., 2010). Interestingly, the constellation of EEG
abnormalities and behavioral impairments were remediated by treatment with baclofen, a
GABA-B agonist (Gandal et al., 2012b), lending preclinical support to a therapeutic
approach trialed in ASD and highlighting the utility of EEG in rodent studies as a measure
of treatment responsiveness.
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Cell-type specific NMDA receptor ablation also results in ASD-relevant circuit changes and
behavioral deficits (Carlén et al., 2012; Saunders et al., 2013), but to a lesser extent than the
constitutive knockdown described above. Knockout of GluN1 selectively in PV-positive
interneurons increased N1 latency in auditory cortex and deceased social preference
(Billingslea et al., 2014; Saunders et al., 2013). Decreased premating ultrasonic
vocalizations in PV-selective GluN1 KO mice were also described, but other behaviors such
as spatial working memory were intact. Increased baseline gamma power and decreased
light-evoked gamma power have also been also identified in PV-selective GluN1 KO mice
using EEG (Billingslea et al., 2014) and also local field potential measurement and
optogenetic stimulation (Carlén et al., 2012), but baseline gamma increases were less
prominent when recorded in awake animals using EEG. These electrophysiological
abnormalities were accompanied by impaired habituation and subtle spatial working
memory deficits (Carlén et al., 2012). Consistent with these studies, and supporting the
presence of an ASD-relevant phenotype in mice lacking the NMDA receptor in interneurons,
mice expressing Cre recombinase under the Ppplr2 promoter (expressed predominantly in
interneurons) displayed impaired neuronal synchrony (measured by single unit recordings),
alongside decreased PPI and spatial working memory (Belforte et al., 2010). These findings
further strengthen the validity of rodent models of NMDA receptor hypofunction,
particularly in PV-positive interneurons, for investigation of sensory processing in ASD.
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Finally, transient blockade of NMDA receptors can also mimic sensory processing deficits
seen in ASD. Treatment of mice with NMDA receptor antagonist MK801 increases N1 ERP
latency, disrupts PPI and baseline gamma power, but decreases evoked gamma power and
phase synchrony (ITC) and (Bakshi and Geyer, 1998; Bast et al., 2000; Saunders et al.,
2012), resulting in a phenotype similar to that seen in ASD (Gandal et al., 2010; McFadden
et al., 2012; Orekhova et al., 2008; Rojas et al., 2011, 2008). Treatment with ketamine, an
NMDA receptor antagonist which also acts at other sites, also increases baseline gamma
power and decreases MMN (Ehrlichman et al., 2009; Ehrlichman et al., 2008; Lazarewicz et
al., 2010; Long et al., 2015). However, it decreases rather than increases N1 latency
(Connolly et al., 2004; Maxwell et al., 2006) and increases rather than decreases evoked
gamma power (Lazarewicz et al., 2010). Interestingly, chronic ketamine exposure in juvenile
mice rather than adults induces different deficits in ERPs and neural oscillations
(Featherstone et al., 2014). Juvenile ketamine exposure (from post-natal days 28–42) does
not increase baseline gamma oscillations over and above the normal developmental increase
in gamma power, but results in the delayed emergence of decreased total event-related
gamma power and decreased P20 amplitude (Featherstone et al., 2014). Broadly speaking,
the deficits of baseline and auditory-evoked neural oscillations arising from
pharmacologically-induced NMDA receptor hypofunction mirror deficits seen in
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constitutively GluN1-underexpressing GluN1neo−/− mice (Gandal et al., 2012b), but likely
depend on age of exposure and the pharmacological properties of the antagonist. Overall,
these models suggest that transgenic rodents whose neurological and behavioral
abnormalities recapitulate deficits in ASD may be useful tools in understanding underlying
cellular and circuit pathologies in the disorders.

5. Key similarities and differences in sensory processing measures
between ASD and FXS

Author Manuscript

As the most common known genetic cause of ASD, FXS can be used powerfully as a
window into pathophysiological mechanisms in ASD. However, only one quarter and one
third of individuals with FXS are also diagnosed with ASD (Bailey et al., 2008; Rogers et
al., 2001), and individuals with FXS who do not have ASD display sensory processing
abnormalities similar to, but not the same as, those seen in ASD. It follows, therefore, that
some objective sensory processing measures which are similarly dysregulated in FXS and
ASD may shed light on mechanisms underlying shared sensory processing deficits, while
other measures which display different patterns of dysregulation may illuminate aspects of
sensory processing which are distinct in the two disorders.
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The sensory processing measures which appear to be most consistent between FXS and
ASD are sensory filtering and attentional orienting measures, MMN and the P3a
respectively. These measures are both evaluated in paradigms which feature rare, deviant
stimuli and can be tailored to target filtering of speech or non-speech auditory stimuli.
Although findings with MMN in ASD are variable, many studies have reported decreased
MMN (Abdeltawwab and Baz, 2015; Dunn et al., 2008; Kuhl et al., 2005; Kujala et al.,
2010; Lepisto et al., 2005, 2006; Ludlow et al., 2014), which is negatively correlated with
symptom severity (Abdeltawwab and Baz, 2015; Kuhl et al., 2005; Ludlow et al., 2014).
Decreased MMN is also reported in FXS (Van der Molen et al., 2012b). Similarly, a
consistent picture of decreased P3a amplitude, particularly with speech-like stimuli in
individuals greater than 10 years of age, has emerged (Ceponiene et al., 2003; Ferri et al.,
2003; Lepisto et al., 2005, 2006), consistent with the decreased P3a amplitude observed in
FXS (Van der Molen et al., 2012a,b). It is plausible that sensory filtering and attentional
orienting mechanisms underlying MMN and the P3a represent points of convergence for
sensory processing deficits in FXS and ASD. In contrast, ERP abnormalities such as N1
amplitude, N1 latency and N2 amplitude consistently display opposite patterns of
dysregulation in FXS and ASX (Brandwein et al., 2015; Bruneau et al., 1999; Castrén et al.,
2003; Gage et al., 2003; Gandal et al., 2010; Korpilahti et al., 2007; Lepisto et al., 2005;
Roberts et al., 2010; Rojas et al., 2001; Seri et al., 1999; St Clair et al., 1987; Van der Molen
et al., 2012a,b). As a result, it is possible that early auditory processing mechanisms
supporting generation of early ERP components are dysregulated in different ways in FXS
and ASD, resulting in divergent sensory processing abnormalities in some areas. It is
important to note that more work needs to be done in FXS to examine spectral
characteristics of EEGs to determine if similarities with ASD exist in these measurements.
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One way in which future studies of FXS could further strengthen understanding of ASD
would be for such studies to subgroup FXS individuals into those with and without ASD.
Subgrouping of those with comorbid intellectual disability and those without would also be
beneficial. Although challenging due to the low incidence of FXS, such an approach would
enable disentangling of the mechanisms underlying the emergence of ASD phenotypes from
those underlying other symptom features of FXS.
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The models described above also have cross-diagnostic utility for understanding
impairments of sensory processing. Although the main focus of this review is on autism and
FSX, it is important to realize that many of the electrophysiological measures that are
described in this review have also been implicated in schizophrenia. Similarities such as
increased baseline gamma power, decreased evoked gamma power, decreased P1
suppression and decreased PPI (Braff et al., 1992; Freedman et al., 1996, 1983; Hanlon et
al., 2005; Kwon et al., 1999; Spencer et al., 2003), as well as decreased MMN amplitude in
both disorders (Atkinson et al., 2012; Baldeweg et al., 2002) have been reported in both
ASD and schizophrenia. However, other studies indicate that there might be marked
differences, such as that some studies found normal levels of both PPI and P1 suppression in
children with autism (Kemner et al., 2002; Kohl et al., 2014; Madsen et al., 2015; Oranje et
al., 2013b; Ornitz et al., 1993), while deficient levels are robustly found in schizophrenia
(Aggernaes et al., 2010; Braff et al., 2001; Oranje et al., 2013a; Thibaut et al., 2015). There
seems to be at least some overlap between schizophrenia and autism symptoms: in two
Danish register based studies it was shown that, dependent on the specific form of autism, up
to 30% of individuals with a childhood diagnose of autism develop a schizophrenia spectrum
disorder later in life (Mouridsen et al., 2008a,b), while parental reports suggest that up to
60% of patients with schizophrenia have had a history with autistic symptoms (Unenge
Hallerback et al., 2012).

6. Overlapping sensory processing deficits in ASD and schizophrenia
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Although the main focus of this review is on autism and FSX, it is important to realize that
most of the electrophysiological measures that are described in this review have also been
implicated in schizophrenia. Similarities such as increased baseline gamma power, decreased
evoked gamma power, decreased P1 suppression and decreased PPI (Braff et al., 1992;
Freedman et al., 1996, 1983; Hanlon et al., 2005; Kwon et al., 1999; Spencer et al., 2003), as
well as decreased MMN amplitude in both disorders (Atkinson et al., 2012; Baldeweg et al.,
2002) have been reported in both ASD and schizophrenia. However, other studies indicate
that there might be marked differences, such as that some studies found normal levels of
both PPI and P1 suppression in children with autism (Kemner et al., 2002; Kemner et al.,
1995; Kohl et al., 2014; Madsen et al., 2015; Oranje et al., 2013b; Ornitz et al., 1993), while
deficient levels are robustly found in schizophrenia (Aggernaes et al., 2010; Braff et al.,
2001; Oranje et al., 2013a; Thibaut et al., 2015). There seems to be at least some overlap
between schizophrenia and autism symptoms: in two Danish register based studies it was
shown that, dependent on the specific form of autism, up to 30% of individuals with a
childhood diagnose of autism develop a schizophrenia spectrum disorder later in life
(Mouridsen et al., 2008a,b), while parental reports suggest that up to 60% of patients with
schizophrenia have had a history with autistic symptoms (Unenge Hallerback et al., 2012).
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7. Concluding discussion
Sensory dysfunction, particularly in the auditory domain, is consistently seen in ASD and
FXS. Basic sensory processing circuitry may be relatively more tractable compared to
circuits involved in social communication and cognitive aspects of ASD. Circuitry involved
in basic sensory processing may also be more conserved across humans and mice compared
to circuits involved in cognitive and social communication. These observations suggest that
sensory processing offers a unique opportunity to understand the patho-physiology of
ASD/FXS at a circuit and cellular level. Future studies are required to elucidate the
molecular mechanisms of altered auditory subcortical and cortical processing and how these
differences correlate with auditory behaviors in ASD and FXS.
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ASD and FXS are neurodevelopmental disorders, but little is known about how the auditory
processing deficits develop, and how these deficits impact the further development of the
brain. Therefore, additional behavioural and anatomical studies in humans and animals, as
well as in vivo single neuron and ERP recordings in animals, are required. Such studies may
identify correlations between developmental hyper-excitability, habituation deficits and
responses to treatments, enabling identification of specific patient subgroups suited to
specific therapeutic approaches. In rats and mice, it will be important to study how proteins
implicated in ASD and FXS, such as CNTNAP2 and FMRP, contribute to the normal
developmental maturation of neurons, auditory circuits, and e.g. ERP responses. Ultimately,
studies of sensory processing in ASD and FXS may reveal mechanisms underlying
developmental disruptions in ASD and FXS, offering hope for individually targeted, agespecific therapeutic approaches in the future.
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Schematic representation of human and rodent EEG electrode placement, ERPs and gamma
oscillations.
A) Human scalp EEG array using the International 10–20 System for electrode placement;
B) example of rodent EEG using implanted tripolar electrodes; C) schematic representation
of stereotypical auditory-evoked ERP with characteristic positive and negative voltage
deflections. ERP latencies and peaks can vary according to electrode placement,
experimental paradigm and species; D) example of neural oscillations-gamma oscillations at
baseline and following auditory stimulus, contrasting wildtype and GluN1 knockout mice. S
– stimulus, KO – knockout, WT – wildtype. Panel B adapted from Connolly et al. (2003)
with permission, panel C adapted from Gandal et al. (2012b) with permission.
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Comparison of sensory processing deficits in Autism Spectrum Disorder and Fragile X Syndrome, as
measured by EEG, MEG and EMG. Refer to the text for discussion of possible reasons for divergent findings;
*to our knowledge.
Objective measure of auditory
sensory processing

Author Manuscript
Author Manuscript

Autism Spectrum Disorder

Fragile X syndrome

P1 amplitude

Decreased P1 amplitude (Ceponiene et al., 2003; Lepisto
et al., 2005; Stroganova et al., 2013); (Asperger’s
syndrome- Madsen et al., 2015)

Not investigated/described*

latency

Increased M50 (MEG P1) latency (Oram Cardy et al.,
2008)

Not investigated/described*

N1 amplitude

Decreased N1 amplitude (Brandwein et al., 2015; Bruneau
et al., 1999; Gandal et al., 2010; Seri et al., 1999) Normal
N1 amplitude (Ceponiene et al., 2003; Madsen et al.,
2015)

Increased N1/M100 (MEG N1)
amplitude (Castrén et al., 2003; Rojas
et al., 2001; St Clair et al., 1987; Van
der Molen et al., 2012a,b)

latency

Increased N1/M100 (MEG N1) latency (Gage et al., 2003;
Gandal et al., 2010; Korpilahti et al., 2007; Roberts et al.,
2010) Normal N1 latency (Bruneau et al., 1999;
Ceponiene et al., 2003; Madsen et al., 2015)

Decreased M100 latency (MEG N1)
(Rojas et al., 2001) Normal N1 latency
(Van der Molen et al., 2012a,b)

P2 amplitude

Not investigated/described*

Increased P2 amplitude (Van der
Molen et al., 2012b) Normal P2
amplitude (Van der Molen et al.,
2012a)

latency

Not investigated/described*

Normal P2 latency (Van der Molen et
al., 2012a,b)

N2 amplitude

Decreased N2 amplitude (Lepisto et al., 2005)

Increased N2b amplitude (Van der
Molen et al., 2012a,b)

latency

Normal N2 latency (Lepisto et al., 2005)

Increased N2b latency (Van der Molen
et al., 2012a,b)

P3a,b amplitude (pure tones)

Increased P3a amplitude (childhood- Ferri et al., 2003)
Decreased P3a amplitude (young adult- Ferri et al., 2003)
Normal P3a amplitude (Lepisto et al., 2005, 2006)

Decreased P3a,b amplitude (Van der
Molen et al., 2012a,b)

amplitude (speech-like stimuli)

Decreased P3a amplitude (Ceponiene et al., 2003; Lepisto
et al., 2005, 2006)

Not investigated/described*

P1 (P50) suppression

Decreased P1 suppression (Orekhova et al., 2008);
(Madsen et al., 2015) Normal P1 suppression (Kemner et
al., 2002; Madsen et al., 2015; Magnee et al., 2009)

Not investigated/described*

Event-related potentials

Startle reactivity, prepulse inhibition
and startle habituation
Acoustic startle response magnitude

Increased startle magnitude (Chamberlain et al., 2013;
Dichter et al., 2010; Kohl et al., 2014; Takahashi et al.,
2016; Wilbarger et al., 2009) Normal startle magnitude
(Bernier et al., 2005; McAlonan et al., 2002; Salmond et
al., 2003; Sterling et al., 2013; Yuhas et al., 2011)

Normal startle magnitude (Frankland
et al., 2004)

Author Manuscript

latency

Increased startle latency (Ornitz et al., 1993; Takahashi et
al., 2016; Yuhas et al., 2011) Normal startle latency
(Bernier et al., 2005)

Normal startle latency (Yuhas et al.,
2011)

PPI

Decreased PPI (adults (McAlonan et al., 2002; Perry et
al., 2007)) Increased PPI (children (Madsen et al., 2014))
Normal PPI (adults and children (Kohl et al., 2014; Oranje
et al., 2013b; Ornitz et al., 1993; Takahashi et al., 2016;
Yuhas et al., 2011))

Decreased PPI (Frankland et al., 2004;
Yuhas et al., 2011)

Habituation

Decreased habituation of ASR (Ornitz et al., 1993; Perry
et al., 2007)

Not investigated/described*

Mismatch negativity
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Author Manuscript

Objective measure of auditory
sensory processing

Autism Spectrum Disorder

Fragile X syndrome

Pure tone-frequency deviant

Decreased MMN (Abdeltawwab and Baz, 2015; Dunn et
al., 2008) Increased MMN (Ferri et al., 2003) Normal
MMN (Jansson-Verkasalo et al., 2003; Weismuller et al.,
2015)

Decreased MMN (pure tone frequency
deviant) (Van der Molen et al., 2012b)

Pure tone-duration deviant

Decreased MMN (Lepisto et al., 2005, 2006) Normal
MMN (Weismuller et al., 2015)

Not investigated/described*

Speech-like stimuli-frequency deviant,
word/vowel change

Decreased MMN (Kuhl et al., 2005; Kujala et al., 2010;
Ludlow et al., 2014) Increased MMN (Korpilahti et al.,
2007; Lepisto et al., 2005, 2006) Normal MMN
(Ceponiene et al., 2003; Kasai et al., 2005; Oram Cardy et
al., 2005; Weismuller et al., 2015)

Not investigated/described*

Speech-like stimuli-duration deviant

Decreased MMN (Lepisto et al., 2006) Normal MMN
(Lepisto et al., 2005).

Not investigated/described*

MMN-all stimuli

Decreased MMN lateralization (Korpilahti et al., 2007;
Kuhl et al., 2005; Weismuller et al., 2015) Abnormal
MMN lateralization (Jansson-Verkasalo et al., 2003;
Lepisto et al., 2006)

Not investigated/described*

Increased baseline delta (1–3 Hz), theta (4–8 Hz), beta
(13–30 Hz) and gamma (30–80 Hz) power (Machado et
al., 2013; Orekhova et al., 2007, 2008; van Diessen et al.,
2014; Wang et al., 2013)

Increased baseline theta power (4–8
Hz) (Van der Molen and Van der
Molen, 2013)

Decreased baseline alpha (8–12 Hz) power (Machado et
al., 2013; Orekhova et al., 2007, 2008; van Diessen et al.,
2014; Wang et al., 2013)

Decreased baseline upper-alpha power
(10–12 Hz) (Van der Molen and Van
der Molen, 2013)

Not investigated/described*

Increased resting theta functional
connectivity (van der Molen et al.,
2014)

Not investigated/described*

Decreased resting upper alpha and beta
functional connectivity (van der Molen
et al., 2014)

Increased auditory-evoked gamma power (McFadden et
al., 2012; Rojas et al., 2001, 2008)
Decreased evoked synchrony across theta and gamma
frequency bands (Jochaut et al., 2015)

Not investigated/described*
Not investigated/described*

Neural oscillations
Baseline power of oscillations

Auditory-evoked power/synchrony of
oscillations

Author Manuscript
Author Manuscript
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Author Manuscript

Author Manuscript
Increased N1, P2 and N2b
amplitudes

FXS

?
?
?
?
?
? N/A

BK channel KO

P2 × 4 receptor KO
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NL-3 mutant (R451C)

NL-3 KO

BTBR T+ Itpr3 tf/J

16p11.2 +/−

? N/A

?

?

?

?

?

?

=(Silverman et al., 2010)
=(Brunner et al., 2015) mice deaf
(Portmann et al., 2014; Yang et al., 2015)

=(Brunner et al., 2015) mice deaf
(Portmann et al., 2014; Yang et al.,
2015)

=(Radyushkin et al., 2009)

=(Chadman et al., 2008)

Decreased (Wyatt et al., 2013)

Decreased (Typlt et al., 2013a)

Increased (DeLorey et al., 2011)

Increased (Wurzman et al., 2015)

Increased (Moy et al., 2014)

Increased (Chao et al., 2010)

Increased (Chao et al., 2010; Samaco et
al., 2008; Samaco et al., 2013)

?

Decreased (Schneider and Przewlocki,
2005; Schneider et al., 2006)

Increased (Chen and Toth, 2001;
Frankland et al., 2004; Olmos-Serrano et
al., 2011)

Decreased

?

PPI

=(Silverman et al., 2010)

=(Radyushkin et al., 2009)

Decreased (Chadman et al., 2008)

Decreased (Wyatt et al., 2013)

Decreased (Typlt et al., 2013a)

Decreased (DeLorey et al., 2011)

Decreased (Wurzman et al., 2015)

?

Gabrb3 +/−

?

?

Ephrin-A2/-A3 KO

Decreased (Chao et al., 2010; Samaco
et al., 2008; Samaco et al., 2013)

Decreased (Moy et al., 2014)

?

?

?

?

Increased N1 amplitude
Increased P2 latency (Liao
et al., 2012)

MeCP2 +/−

?

=(Schneider and Przewlocki, 2005;
Schneider et al., 2006)

C58/J

Decreased N1 and P2
amplitudes Increased P1,
N1 and P2 latencies
(Goffin et al., 2011).

MeCP2 T158A

?

Decreased (Chen and Toth, 2001;
Olmos-Serrano et al., 2011)

=

Increased

Startle

Decreased (Chao et al., 2010)

Increased N1 latency
(Gandal et al., 2010)

Prenatal VPA

?

Decreased

Decreased (?)

MMN

MeCP2 (interneuron KO)

=Decreased habituation of
N1 amplitude (Lovelace et
al., 2016)

Fmr1 KO

ASD- and FXS-relevant mouse models

Decreased P1, N1, N2 and
P3a amplitudes Increased
N1 latency

ASD

Human disorders (refer to Table 1 for references)

ERPs

? N/A

?

?

?

?

?

?

?

?

Decreased evoked theta, alpha and
gamma power/ITC (Goffin et al.,
2014)

Increased evoked gamma power/ITC
(Liao et al., 2012)

Increased baseline gamma power
Decreased evoked theta, alpha and
gamma power/ITC (Goffin et al.,
2011)

?

?

Increased baseline theta power
Decreased baseline alpha power

Increased baseline theta and gamma
Decreased baseline alpha power

Neural oscillations

Changes in sensory processing measures in rodent models that show analogies to the diagnostic symptoms of autism, including low social interactions,
reduced vocalizations in social settings, and/or high levels of repetitive self-grooming. Findings in ASD and FXS are provided at the top of the table for
comparison purposes.
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?
?
?

Nrcam-KO

Shank3

?

?

?

?

?

?

?

?

KO – knockout, ITC – inter-trial coherence, N/A – not applicable.

?

?

Th(tk-)/th (tk-)

Cntnap2 KO

?

PWS-IC(+/−)

Npas4-KO

?

Neurexin-1α KO

Author Manuscript
?

Author Manuscript

PDGFR-β KO

=(Kouser et al., 2013)

=(Moy et al., 2009)

=(Brunner et al., 2015)

Increased (Coutellier et al., 2012)

Increased (Klejbor et al., 2009)

Increased (Relkovic et al., 2010)

=(mouse) (Etherton et al., 2009)
Increased (rat) (Esclassan et al., 2015)

=(Nakamura et al., 2015; Nguyen et al.,
2011)

Startle

=(Kouser et al., 2013)

Decreased (males) (Moy et al., 2009)

Increased (Brunner et al., 2015)

Decreased (Coutellier et al., 2012)

Decreased (Klejbor et al., 2009)

Decreased (Relkovic et al., 2010)

Decreased (mouse) (Etherton et al., 2009)
=(rat) (Esclassan et al., 2015)

Decreased (Nakamura et al., 2015;
Nguyen et al., 2011)

PPI

Author Manuscript

MMN

?

?

?

?

?

?

?

Decreased gamma power and ITC
(Nakamura et al., 2015; Nguyen et
al., 2011)

Neural oscillations

Author Manuscript

ERPs
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Author Manuscript

Author Manuscript

Author Manuscript
Increased N1, P2 and N2b
amplitudes

FXS

Increased N1 latency (Billingslea
et al., 2014; Saunders et al., 2013)
Increased N1 latency (Saunders et
al., 2012)

PV-selective GluN1 KO

NMDAR blockade

KO – knockout, ITC – inter-trial coherence.

Increased N1 latency (Gandal et
al., 2012a)

GluN1neo−/−

ASD- and FXS-relevant mouse models

Decreased P1, N1, N2 and P3a
amplitudes
Increased N1 latency

ASD

Human disorders (refer to Table 1 for references)

ERPs

Decreased (Ehrlichman
et al., 2008)

?

?

Decreased

Decreased (?)

MMN

Increased (Bakshi and
Geyer, 1998; Bast et al.,
2000)

?

Increased (Duncan et al.,
2004; Gandal et al.,
2012a,b; Moy et al.,
2014)

=

Increased

Startle

Decreased (Bakshi and
Geyer, 1998; Bast et al.,
2000)

= (Carlén et al., 2012)

Decreased (Duncan et al.,
2004; Gandal et al.,
2012a,b; Moy et al., 2014)

Decreased

?

PPI

Increased baseline gamma power
Decreased evoked gamma power/ITC (Saunders
et al., 2012)

Increased baseline gamma (Billingslea et al.,
2014; Carlén et al., 2012)

Increased baseline theta and gamma
Decreased evoked gamma power/ITC (Gandal
et al., 2012b)

Increased baseline theta power
Decreased baseline alpha power

Increased baseline theta and gamma
Decreased baseline alpha power

Neural oscillations

Changes in sensory processing measures in rodent models of disrupted excitatory/inhibitory balance that recapitulate ASD phenotypes. Findings in ASD
and FXS are provided at the top of the table for comparison purposes.

Author Manuscript

Table 3
Sinclair et al.
Page 42

Neurosci Biobehav Rev. Author manuscript; available in PMC 2017 June 09.

